The European Commission adopted revised proposals clarifying the information that industry can supply to the public on prescription-only medicines.
Patients are increasingly interested in learning more about the medicines they take and want more of a say in how they are treated. At the same time, patients are confronted with a growing volume of information from various sources and often find it difficult to identify reliable information about medicines.
The increased use of the internet over recent years makes the need for clarity even more important. Online information on medicines must be accurate and reliable.